This information is intended only for healthcare professionals resident in the United Kingdom


Prescribing Information (PI) for Xeljanz ® (tofacitinib)

Pfizer Ltd. accepts no responsibility for the content or services of the linked site other than the information relating to Pfizer medicines which it has provided or reviewed

United Kingdom 

  • Xeljanz (tofacitinib) 5mg film-coated tablets - PI for UK
  • Xeljanz (tofacitinib) 11mg prolonged release tablets - PI for UK
  • Xeljanz (tofacitinib) 10mg prolonged release tablets - PI for UK
  • Xeljanz (tofacitinib) 1mg/ml oral solution - PI for UK

Xeljanz (tofacitinib) 5mg film-coated tablets 

Xeljanz (tofacitinib) 11mg prolonged release tablets

Xeljanz (tofacitinib) 10mg film-coated tablets 

Xeljanz (tofacitinib) 1mg/ml Oral Solution 

PP-XEL-GBR-5140 January 2025